ELTHAM MEDICAL PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: G83680 | LONDON, SE9 5DQ
Showing results 351-400 of 731
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Anastrozole | 78 | 3,472 | £130 | -14.3% ▼ |
| Calcium carbonate | 78 | 5,824 | £545 | +18.5% ▲ |
| Adapalene | 77 | 3,870 | £1.3K | +251.8% ▲ |
| Olmesartan medoxomil | 76 | 3,752 | £388 | +10.3% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 76 | 12.2K | £720 | -49.7% ▼ |
| Azelaic acid | 76 | 2,430 | £392 | +217.9% ▲ |
| Fenofibrate | 75 | 4,390 | £479 | -22.5% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 75 | 119.3K | £2.0K | +96.5% ▲ |
| 75 | 352 | £900 | +209.6% ▲ | |
| Co-tenidone (Atenolol/chlortalidone) | 74 | 3,458 | £469 | +254.8% ▲ |
| Etoricoxib | 74 | 3,444 | £891 | -8.2% ▼ |
| Timolol and travoprost | 73 | 368 | £1.7K | +125.9% ▲ |
| 73 | 73 | £407 | +42.3% ▲ | |
| Hyoscine hydrobromide | 72 | 2,141 | £360 | +110.8% ▲ |
| Alkyl sulphate | 72 | 21.9K | £561 | +679.1% ▲ |
| 72 | 2,910 | £6.7K | +251.2% ▲ | |
| Glucagon | 71 | 97 | £1.3K | +366.7% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 71 | 161.8K | £3.0K | +1.5% vs avg |
| 71 | 4,310 | £13.6K | +110.2% ▲ | |
| 71 | 6,930 | £22.0K | +455.7% ▲ | |
| 71 | 3,450 | £12.4K | +436.1% ▲ | |
| Domperidone | 70 | 22.2K | £4.4K | +96.3% ▲ |
| Clonidine hydrochloride | 70 | 50.5K | £87.9K | +31.2% ▲ |
| Clobazam | 70 | 8,400 | £2.7K | +6.2% ▲ |
| 70 | 6,000 | £2.9K | +262.1% ▲ | |
| Ivermectin | 68 | 3,195 | £1.9K | +219.8% ▲ |
| 68 | 730 | £2.3K | +234.0% ▲ | |
| Rasagiline mesilate | 67 | 3,010 | £1.9K | +80.4% ▲ |
| Brinzolamide and timolol | 67 | 515 | £711 | +77.3% ▲ |
| 67 | 9,201 | £327 | -21.3% ▼ | |
| 67 | 4,120 | £2.7K | +65.2% ▲ | |
| Bezafibrate | 66 | 6,676 | £889 | +22.5% ▲ |
| Dexamethasone | 66 | 4,234 | £894 | +111.8% ▲ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 66 | 2,820 | £181 | +339.3% ▲ |
| Menthol | 66 | 32.5K | £1.2K | +134.4% ▲ |
| Pimecrolimus | 66 | 2,450 | £1.5K | +289.8% ▲ |
| Orlistat | 64 | 6,804 | £1.6K | -22.4% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 64 | 3,800 | £191 | +59.3% ▲ |
| Saxagliptin | 64 | 1,134 | £1.2K | +91.5% ▲ |
| Piroxicam | 64 | 6,908 | £180 | +11.4% ▲ |
| 64 | 782 | £394 | +72.8% ▲ | |
| 64 | 11.6K | £1.6K | +260.3% ▲ | |
| Ethosuximide | 63 | 4,207 | £9.9K | +327.1% ▲ |
| 62 | 17.0K | £354 | -32.0% ▼ | |
| Flecainide acetate | 61 | 5,540 | £222 | -21.9% ▼ |
| Trifluoperazine | 61 | 3,534 | £2.0K | +304.4% ▲ |
| Leflunomide | 61 | 2,910 | £182 | +61.2% ▲ |
| Mycophenolate mofetil | 60 | 7,840 | £2.7K | +48.2% ▲ |
| 60 | 752 | £5.0K | +115.7% ▲ | |
| Rotigotine | 59 | 1,932 | £8.1K | +118.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.